Generali Investments CEE’s Eli Lilly LLY Stock Holding History

Generali Investments CEE’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.82M	Sell	8,184 -1,049	-11%	-$1.07M	0.47%	56
2026 Q1	$8.49M	Sell	9,233 -500	-5%	-$507K	0.45%	61
2025 Q4	$10.5M	Sell	9,733 -1,022	-10%	-$977K	0.74%	28
2025 Q3	$8.21M	Buy	10,755 +307	+3%	+$228K	0.62%	42
2025 Q2	$8.14M	Hold	10,448	–	–	0.67%	34
2025 Q1	$8.63M	Sell	10,448 -542	-5%	-$451K	0.8%	23
2024 Q4	$8.48M	Buy	+10,990	New	+$9.1M	0.87%	22

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Generali Investments CEE's LLY Position: Q2 2026 in Review

Generali Investments CEE reduced its Eli Lilly (LLY) stake by 11% in Q2 2026, selling an estimated $1.07M and leaving 8,184 shares worth $9.82M. The position accounts for 0.47% of the portfolio, ranked #56.

Generali Investments CEE first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. The position peaked at $10.5M in Q4 2025. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Generali Investments CEE held 8,184 shares of Eli Lilly worth $9.82M as of Q2 2026.
Generali Investments CEE sold 1,049 Eli Lilly shares in Q2 2026, an estimated $1.07M.
Eli Lilly made up 0.47% of Generali Investments CEE's portfolio in Q2 2026, its #56 holding.
Generali Investments CEE first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
Generali Investments CEE's Eli Lilly position peaked at $10.5M in Q4 2025.
4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Generali Investments CEE's 13F filing for Q2 2026, filed 13 Jul 2026.